Relating illness complexity to reimbursement in CKD patients

Area of Science:

• Nephrology
• Health Economics
• Biomedical Informatics

Background:

• Electronic health records present challenges in linking healthcare quality to payment.
• Claims data analysis is difficult for evaluating health outcomes and provider compensation.
• Illness complexity significantly impacts treatment outcomes and costs, particularly in chronic kidney disease (CKD).

Purpose of the Study:

• To evaluate an illness complexity score (ICS) for predicting average monthly reimbursements in CKD patients.
• To compare the predictive accuracy of ICS against traditional CKD staging.
• To analyze the longitudinal relationship between ICS, estimated glomerular filtration rate (eGFR), and CKD stage with reimbursement.

Main Methods:

• A linear regression model was developed using 15 blood chemistry values and patient age.
• Data from 177 de-identified CKD patients over 13 months, including bloodwork and claims data, were analyzed.
• The illness complexity score (ICS) was compared against CKD stage for predicting average monthly reimbursements.

Main Results:

• The ICS demonstrated a strong association with average monthly reimbursements (R² = 0.41).
• CKD staging showed a weaker association with reimbursements (R² = 0.08).
• ICS exhibited five times greater sensitivity than CKD staging in measuring illness complexity.

Conclusions:

• The illness complexity score (ICS) provides a more sensitive measure of patient health and reimbursement association compared to CKD staging.
• ICS captures broader patient health status, including dysfunction in other organ systems.
• This scoring method offers improved potential for fair provider compensation in managing complex CKD cases.